|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DK3134131T3
(en)
|
2014-04-23 |
2022-02-07 |
Modernatx Inc |
Nucleic acid vaccines
|
|
MA42502A
(fr)
|
2015-07-21 |
2018-05-30 |
Modernatx Inc |
Vaccins contre une maladie infectieuse
|
|
US11364292B2
(en)
|
2015-07-21 |
2022-06-21 |
Modernatx, Inc. |
CHIKV RNA vaccines
|
|
WO2017020026A1
(en)
|
2015-07-30 |
2017-02-02 |
Modernatx, Inc. |
Concatemeric peptide epitopes rnas
|
|
US11564893B2
(en)
|
2015-08-17 |
2023-01-31 |
Modernatx, Inc. |
Methods for preparing particles and related compositions
|
|
MD3718565T2
(ro)
|
2015-10-22 |
2022-09-30 |
Modernatx Inc |
Vaccinuri împotriva virusului respirator
|
|
EP3364950A4
(en)
|
2015-10-22 |
2019-10-23 |
ModernaTX, Inc. |
VACCINES AGAINST TROPICAL DISEASES
|
|
CN108430456B
(zh)
|
2015-10-22 |
2022-01-18 |
摩登纳特斯有限公司 |
癌症疫苗
|
|
EP3364981A4
(en)
|
2015-10-22 |
2019-08-07 |
ModernaTX, Inc. |
VACCINE AGAINST THE HUMAN CYTOMEGALOVIRUS
|
|
AU2016342376A1
(en)
|
2015-10-22 |
2018-06-07 |
Modernatx, Inc. |
Sexually transmitted disease vaccines
|
|
WO2017070601A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Nucleic acid vaccines for varicella zoster virus (vzv)
|
|
CA3007955A1
(en)
|
2015-12-10 |
2017-06-15 |
Modernatx, Inc. |
Lipid nanoparticles for delivery of therapeutic agents
|
|
US10465190B1
(en)
|
2015-12-23 |
2019-11-05 |
Modernatx, Inc. |
In vitro transcription methods and constructs
|
|
CN114751950B
(zh)
|
2016-03-18 |
2025-04-18 |
免疫传感器公司 |
环二核苷酸化合物及使用方法
|
|
EP3445392A1
(en)
*
|
2016-04-22 |
2019-02-27 |
CureVac AG |
Rna encoding a tumor antigen
|
|
JP7088911B2
(ja)
|
2016-05-18 |
2022-06-21 |
モデルナティエックス インコーポレイテッド |
リラキシンをコードするポリヌクレオチド
|
|
US12128113B2
(en)
|
2016-05-18 |
2024-10-29 |
Modernatx, Inc. |
Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome
|
|
JP6983455B2
(ja)
|
2016-09-14 |
2021-12-17 |
モデルナティーエックス， インコーポレイテッド |
高純度ｒｎａ組成物及びその調製のための方法
|
|
AU2017345766A1
(en)
|
2016-10-21 |
2019-05-16 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|
|
CN110167587A
(zh)
|
2016-11-11 |
2019-08-23 |
摩登纳特斯有限公司 |
流感疫苗
|
|
EP3551193A4
(en)
|
2016-12-08 |
2020-08-19 |
Modernatx, Inc. |
NUCLEIC ACID VACCINES AGAINST RESPIRATORY VIRUSES
|
|
EP3555289A1
(en)
|
2016-12-13 |
2019-10-23 |
ModernaTX, Inc. |
Rna affinity purification
|
|
US11229668B2
(en)
*
|
2017-02-07 |
2022-01-25 |
Nantcell, Inc. |
Maximizing T-cell memory and compositions and methods therefor
|
|
WO2018151816A1
(en)
|
2017-02-16 |
2018-08-23 |
Modernatx, Inc. |
High potency immunogenic compositions
|
|
MA47787A
(fr)
|
2017-03-15 |
2020-01-22 |
Modernatx Inc |
Vaccin contre le virus respiratoire syncytial
|
|
WO2018170245A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
|
US11752206B2
(en)
*
|
2017-03-15 |
2023-09-12 |
Modernatx, Inc. |
Herpes simplex virus vaccine
|
|
WO2018170270A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Varicella zoster virus (vzv) vaccine
|
|
WO2018170347A1
(en)
|
2017-03-17 |
2018-09-20 |
Modernatx, Inc. |
Zoonotic disease rna vaccines
|
|
WO2018187590A1
(en)
|
2017-04-05 |
2018-10-11 |
Modernatx, Inc. |
Reduction or elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins
|
|
WO2018232357A1
(en)
|
2017-06-15 |
2018-12-20 |
Modernatx, Inc. |
Rna formulations
|
|
WO2019036685A1
(en)
|
2017-08-18 |
2019-02-21 |
Modernatx, Inc. |
METHODS FOR HPLC ANALYSIS
|
|
WO2019036683A1
(en)
|
2017-08-18 |
2019-02-21 |
Modernatx, Inc. |
ANALYTICAL METHODS BY HPLC
|
|
CN111212905A
(zh)
|
2017-08-18 |
2020-05-29 |
摩登纳特斯有限公司 |
Rna聚合酶变体
|
|
WO2019046809A1
(en)
|
2017-08-31 |
2019-03-07 |
Modernatx, Inc. |
METHODS OF MANUFACTURING LIPID NANOPARTICLES
|
|
US10653767B2
(en)
|
2017-09-14 |
2020-05-19 |
Modernatx, Inc. |
Zika virus MRNA vaccines
|
|
WO2019148101A1
(en)
|
2018-01-29 |
2019-08-01 |
Modernatx, Inc. |
Rsv rna vaccines
|
|
MX2020012649A
(es)
*
|
2018-05-25 |
2021-07-02 |
The Wistar Inst |
Neoantígenos especificos de tumor y métodos de uso de estos.
|
|
SG11202012770RA
(en)
*
|
2018-06-27 |
2021-01-28 |
Modernatx Inc |
Personalized cancer vaccine epitope selection
|
|
US20220349010A1
(en)
|
2018-07-26 |
2022-11-03 |
Frame Pharmaceuticals B.V. |
Method of preparing subject-specific immunogenic compositions based on a neo open-reading-frame peptide database
|
|
IL280112B2
(en)
|
2018-07-26 |
2025-11-01 |
Curevac Netherlands B V |
Cancer vaccines for breast cancer
|
|
US12151029B2
(en)
|
2018-09-19 |
2024-11-26 |
Modernatx, Inc. |
PEG lipids and uses thereof
|
|
AU2019345067A1
(en)
|
2018-09-19 |
2021-04-08 |
Modernatx, Inc. |
High-purity peg lipids and uses thereof
|
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
CN112867501B
(zh)
|
2018-10-19 |
2025-01-07 |
弗朗西斯·克里克研究所有限公司 |
新的癌抗原和方法
|
|
CA3118947A1
(en)
*
|
2018-11-07 |
2020-05-14 |
Modernatx, Inc. |
Rna cancer vaccines
|
|
TWI852977B
(zh)
|
2019-01-10 |
2024-08-21 |
美商健生生物科技公司 |
前列腺新抗原及其用途
|
|
EP3911678A1
(en)
*
|
2019-01-14 |
2021-11-24 |
Genentech, Inc. |
Methods of treating cancer with a pd-1 axis binding antagonist and an rna vaccine
|
|
US11351242B1
(en)
|
2019-02-12 |
2022-06-07 |
Modernatx, Inc. |
HMPV/hPIV3 mRNA vaccine composition
|
|
JP2022521094A
(ja)
|
2019-02-20 |
2022-04-05 |
モデルナティエックス インコーポレイテッド |
共転写キャッピング用ｒｎａポリメラーゼバリアント
|
|
US11851694B1
(en)
|
2019-02-20 |
2023-12-26 |
Modernatx, Inc. |
High fidelity in vitro transcription
|
|
CN113874502A
(zh)
|
2019-03-11 |
2021-12-31 |
摩登纳特斯有限公司 |
补料分批体外转录方法
|
|
AU2020234003B2
(en)
*
|
2019-03-11 |
2026-02-12 |
Evaxion A/S |
Nucleic acid vaccination using neo-epitope encoding constructs
|
|
WO2020190750A1
(en)
|
2019-03-15 |
2020-09-24 |
Modernatx, Inc. |
Hiv rna vaccines
|
|
JP7744829B2
(ja)
*
|
2019-03-25 |
2025-09-26 |
オハイオ・ステイト・イノベーション・ファウンデーション |
組み合わせ免疫調節及びその使用
|
|
WO2020242720A1
(en)
*
|
2019-05-02 |
2020-12-03 |
University Of Florida Research Foundation, Inc. |
Compositions for treatment of diffuse intrinsic pontine glioma
|
|
JP2022535006A
(ja)
*
|
2019-05-31 |
2022-08-04 |
モデルナティエックス インコーポレイテッド |
増殖ｔ細胞アッセイ
|
|
US12577278B2
(en)
*
|
2019-06-07 |
2026-03-17 |
Emory University |
KRAS G12V mutant binds to JAK1, inhibitors, pharmaceutical compositions, and methods related thereto
|
|
CN110172480B
(zh)
*
|
2019-06-11 |
2020-01-07 |
北京鼎成肽源生物技术有限公司 |
双抗原表位融合基因重组慢病毒载体、抗原提呈细胞和ctl细胞及其构建方法和应用
|
|
CN110172089B
(zh)
*
|
2019-06-11 |
2020-01-07 |
北京鼎成肽源生物技术有限公司 |
一种kras突变多抗原组合、靶向kras突变肿瘤ctl及其应用
|
|
WO2021038089A1
(en)
*
|
2019-08-29 |
2021-03-04 |
Universität Zürich |
Minimal messenger rnas and uses thereof
|
|
CN114980920A
(zh)
|
2019-11-18 |
2022-08-30 |
詹森生物科技公司 |
基于突变体calr和jak2的疫苗及其用途
|
|
WO2021119418A1
(en)
*
|
2019-12-11 |
2021-06-17 |
Vanderbilt University |
Methods of synthesizing mrna and functional proteins from synthetic double stranded dna
|
|
EP4096720A2
(en)
*
|
2020-01-30 |
2022-12-07 |
ModernaTX, Inc. |
Mrnas encoding metabolic reprogramming polypeptides and uses thereof
|
|
KR20220136378A
(ko)
*
|
2020-01-31 |
2022-10-07 |
제넨테크, 인크. |
Pd-1 축 결합 길항제 및 rna 백신을 이용하여 네오에피토프-특이적 t 세포를 유도하는 방법
|
|
WO2021158996A1
(en)
*
|
2020-02-05 |
2021-08-12 |
University Of Florida Research Foundation, Incorporated |
Rna-loaded nanoparticles and use thereof for the treatment of cancer
|
|
IL296234A
(en)
*
|
2020-03-11 |
2022-11-01 |
Advansix Resins & Chemicals Llc |
Surfactants for healthcare products
|
|
EP4118067A1
(en)
|
2020-03-11 |
2023-01-18 |
AdvanSix Resins & Chemicals LLC |
Surfactants for agricultural products
|
|
AU2021236069B9
(en)
|
2020-03-11 |
2024-02-01 |
Advansix Resins & Chemicals Llc |
Surfactants for oil and gas production
|
|
WO2021209775A1
(en)
*
|
2020-04-17 |
2021-10-21 |
The Francis Crick Institute Limited |
Antigen pool
|
|
CN113521269A
(zh)
|
2020-04-22 |
2021-10-22 |
生物技术Rna制药有限公司 |
冠状病毒疫苗
|
|
US11130787B2
(en)
*
|
2020-06-11 |
2021-09-28 |
MBF Therapeutics, Inc. |
Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods
|
|
WO2022006368A2
(en)
|
2020-07-02 |
2022-01-06 |
Life Technologies Corporation |
Trinucleotide cap analogs, preparation and uses thereof
|
|
WO2022009052A2
(en)
|
2020-07-06 |
2022-01-13 |
Janssen Biotech, Inc. |
Prostate neoantigens and their uses
|
|
WO2022031021A1
(ko)
*
|
2020-08-04 |
2022-02-10 |
성균관대학교산학협력단 |
동력학적 제어가 가능한 아주번트를 포함하는 mrna 백신
|
|
JP2023539454A
(ja)
|
2020-08-12 |
2023-09-14 |
アクティム・セラピューティクス・インコーポレイテッド |
免疫刺激細菌ベースのワクチン、治療薬およびｒｎａデリバリープラットフォーム
|
|
US11406703B2
(en)
|
2020-08-25 |
2022-08-09 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|
|
CA3198727A1
(en)
|
2020-10-20 |
2022-04-28 |
St Pharm Co., Ltd. |
Oligonucleotide for 5'-capped rna synthesis
|
|
WO2022087424A1
(en)
*
|
2020-10-22 |
2022-04-28 |
The Regents Of The University Of California |
Monoamine oxidase blockade therapy for treating cancer through regulating tumor associated macrophages (tams)
|
|
WO2022120560A1
(zh)
*
|
2020-12-08 |
2022-06-16 |
深圳市瑞吉生物科技有限公司 |
一种mRNA剂型的免疫抑制剂及其在制备肿瘤治疗药物中的应用
|
|
WO2022140278A1
(en)
*
|
2020-12-21 |
2022-06-30 |
University Of Florida Research Foundation, Inc. |
Multilamellar rna nanoparticle vaccine against cancer
|
|
CN114717229B
(zh)
*
|
2021-01-05 |
2024-09-10 |
麦塞拿治疗(香港)有限公司 |
治疗性mRNA的无细胞和无载体体外RNA转录方法和核酸分子
|
|
WO2022150717A1
(en)
|
2021-01-11 |
2022-07-14 |
Modernatx, Inc. |
Seasonal rna influenza virus vaccines
|
|
EP4291229A4
(en)
*
|
2021-02-09 |
2025-03-26 |
Virginia Commonwealth University |
Mini circular rna therapeutics and vaccines and methods of use thereof
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
JP2024511179A
(ja)
*
|
2021-03-26 |
2024-03-12 |
モデルナティエックス インコーポレイテッド |
百日咳ワクチン
|
|
NL2028681B1
(en)
*
|
2021-04-02 |
2022-10-17 |
Nutcracker Therapeutics Inc |
Materials and methods for generating antigen-specific t cells and treating diseases
|
|
CN113186285B
(zh)
*
|
2021-05-10 |
2022-05-24 |
深圳市展行生物有限公司 |
一种辅助诊断胃癌的方法及其使用的miRNA组合
|
|
US20220363937A1
(en)
|
2021-05-14 |
2022-11-17 |
Armstrong World Industries, Inc. |
Stabilization of antimicrobial coatings
|
|
CN113577258B
(zh)
*
|
2021-07-31 |
2024-04-16 |
山东兴瑞生物科技有限公司 |
一种双靶点mRNA疫苗及其制备方法
|
|
CN115703714B
(zh)
*
|
2021-08-13 |
2025-06-10 |
广州谷森制药有限公司 |
阳离子脂质化合物
|
|
WO2023030635A1
(en)
*
|
2021-09-02 |
2023-03-09 |
BioNTech SE |
Potency assay for therapeutic potential of coding nucleic acid
|
|
EP4147712A1
(en)
|
2021-09-13 |
2023-03-15 |
OncoDNA |
Method to generate a double-stranded dna pool encoding neoantigens of a tumor of a patient
|
|
IL311304A
(en)
|
2021-09-13 |
2024-05-01 |
Oncodna |
A method for creating personal neoantigens from a patient's growth
|
|
EP4147713A1
(en)
*
|
2021-09-13 |
2023-03-15 |
OncoDNA |
A rna vaccine comprising an rna pool generated from a double-stranded dna pool
|
|
CA3235418A1
(en)
|
2021-11-09 |
2023-05-19 |
Actym Therapeutics, Inc. |
Immunostimulatory bacteria for converting macrophages into a phenotype amenable to treatment, and companion diagnostic for identifying subjects for treatment
|
|
US12186387B2
(en)
|
2021-11-29 |
2025-01-07 |
BioNTech SE |
Coronavirus vaccine
|
|
US12529047B1
(en)
|
2021-12-21 |
2026-01-20 |
Modernatx, Inc. |
mRNA quantification methods
|
|
CN116376942A
(zh)
*
|
2021-12-31 |
2023-07-04 |
广州国家实验室 |
mRNA疫苗
|
|
WO2024002985A1
(en)
|
2022-06-26 |
2024-01-04 |
BioNTech SE |
Coronavirus vaccine
|
|
CN119866224A
(zh)
*
|
2022-07-28 |
2025-04-22 |
加拿大干细胞技术公司 |
编码连接抗原的多核苷酸以及其用途
|
|
CN115992152A
(zh)
*
|
2022-09-22 |
2023-04-21 |
浙江大学医学院附属第一医院 |
一种用于乙型肝炎病毒治疗性mRNA疫苗及其制备方法与应用
|
|
WO2024075851A1
(ja)
*
|
2022-10-07 |
2024-04-11 |
国立大学法人 筑波大学 |
核酸構築物およびタンパク複合体の設計方法および製造方法
|
|
EP4604981A2
(en)
*
|
2022-10-19 |
2025-08-27 |
KaliVir Immunotherapeutics, Inc. |
Nucleic acids encoding soluble pd-1 and il-12 and uses thereof
|
|
CN120225259A
(zh)
*
|
2022-10-31 |
2025-06-27 |
磨石生物公司 |
组合组无细胞dna监测
|
|
EP4612301A1
(en)
*
|
2022-11-03 |
2025-09-10 |
ModernaTX, Inc. |
Chemical stability of mrna
|
|
EP4364752A1
(en)
|
2022-11-07 |
2024-05-08 |
OncoDNA |
Improved vaccine
|
|
CN116970614A
(zh)
*
|
2022-12-29 |
2023-10-31 |
达冕疫苗(广州)有限公司 |
编码ny-eso-1的核糖核酸疫苗的组合物和方法
|
|
US20240238408A1
(en)
*
|
2023-01-17 |
2024-07-18 |
The University Of Hong Kong |
CANCER IMMUNOTHERAPY BY DELIVERY OF mRNA
|
|
CN119055669A
(zh)
*
|
2023-05-23 |
2024-12-03 |
源生生物科技(青岛)有限责任公司 |
包含miRNA的活性成分及其应用
|
|
WO2025054383A1
(en)
*
|
2023-09-06 |
2025-03-13 |
Modernatx, Inc. |
Chemical stability of mrna
|
|
WO2025080869A1
(en)
*
|
2023-10-11 |
2025-04-17 |
The Regents Of The University Of California |
Pancreatic cancer immunotherapy using cationic lipid and polymer nanocarriers for co-delivery of kras neoantigens and sting and/or other immunomodulators to boost the cancer immunity cycle and treat liver metastasis
|
|
WO2025117816A1
(en)
*
|
2023-12-01 |
2025-06-05 |
Recode Therapeutics, Inc. |
Lipid nanoparticle compositions and uses thereof
|
|
WO2025153053A1
(en)
*
|
2024-01-17 |
2025-07-24 |
Abogen Biosciences (Shanghai) Co., Ltd. |
Composition and methods for inducing antigen specific immunity against kras mutant cells
|
|
WO2025158069A1
(en)
*
|
2024-01-25 |
2025-07-31 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
CONSTRUCT COMPRISING mRNA-STRAND AND RETINOIC ACID-INDUCIBLE GENE I (RIG-I)-LIGAND(S), PHARMACEUTICAL COMPOSITION AND KIT COMPRISING THE SAME
|
|
CN118389553A
(zh)
*
|
2024-03-01 |
2024-07-26 |
中国科学技术大学 |
免疫增效rna分子及其组合物、疫苗与试剂盒
|
|
CN117883558B
(zh)
*
|
2024-03-15 |
2024-06-14 |
山东兴瑞生物科技有限公司 |
靶向肝肿瘤个性化mRNA疫苗的制备方法
|
|
WO2025235990A1
(en)
*
|
2024-05-10 |
2025-11-13 |
Metrohealth Ventures Llc |
Cancer oncogene mrna vaccine
|
|
WO2026005647A2
(ru)
*
|
2024-06-29 |
2026-01-02 |
федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации |
Иммунобиологическое средство для терапии онкологических заболеваний на основе мрнк вектора
|
|
CN119874872B
(zh)
*
|
2025-01-17 |
2025-11-25 |
武汉大学 |
一种mita铰链区突变多肽及其在自身免疫性疾病中的应用
|